ArticlePloS one2023
Semi-supervised nuclei segmentation based on multi-edge features fusion attention network.
Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 9 citations in OpenAlex.
- Semi-supervised semantic segmentation of cell nuclei with diffusion model and collaborative learning.Journal of medical imaging (Bellingham, Wash.) · 2025Article
- A semi-supervised convolutional neural network for diagnosis of pancreatic ductal adenocarcinoma based on EUS-FNA cytological images.BMC cancer · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The morphology of the nuclei represents most of the clinical pathological information, and nuclei segmentation is a vital step in current automated histopathological image analysis. Supervised machine learning-based segmentation models have already achieved outstanding performance with sufficiently precise human annotations. Nevertheless, outlining such labels on numerous nuclei is extremely professional needing and time consuming. Automatic nuclei segmentation with minimal manual interventions is highly needed to promote the effectiveness of clinical pathological researches. Semi-supervised learning greatly reduces the dependence on labeled samples while ensuring sufficient accuracy. In this paper, we propose a Multi-Edge Feature Fusion Attention Network (MEFFA-Net) with three feature inputs including image, pseudo-mask and edge, which enhances its learning ability by considering multiple features. Only a few labeled nuclei boundaries are used to train annotations on the remaining mostly unlabeled data. The MEFFA-Net creates more precise boundary masks for nucleus segmentation based on pseudo-masks, which greatly reduces the dependence on manual labeling. The MEFFA-Block focuses on the nuclei outline and selects features conducive to segment, making full use of the multiple features in segmentation. Experimental results on public multi-organ databases including MoNuSeg, CPM-17 and CoNSeP show that the proposed model has the mean IoU segmentation evaluations of 0.706, 0.751, and 0.722, respectively. The model also achieves better results than some cutting-edge methods while the labeling work is reduced to 1/8 of common supervised strategies. Our method provides a more efficient and accurate basis for nuclei segmentations and further quantifications in pathological researches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.